글로벌 모세혈관 혈액 수집 및 샘플링 장치 시장 – 2030년까지의 산업 동향 및 예측

 모세혈관 혈액 수집 및 샘플링 장치 시장 분석 및 규모

병원 수술 시술의 증가는 글로벌 모세혈관 혈액 수집 및 샘플링 장치 시장을 주도하고 있습니다. 화학 요법, 투석, 장기 및 조직 이식, 복잡한 수술을 받는 환자는 혈액 수집 제품의 이점을 누릴 수 있습니다. 앉아서 생활하는 방식으로 인해 만성 및 생활 습관병이 늘어나면서 정기적인 건강 검진을 더욱 철저히 해야 합니다. 이로 인해 모세혈관 혈액 수집 및 샘플링 장치에 대한 수요가 질병 진단의 주요 방법으로 증가했습니다.

Data Bridge Market Research는 2022년에 2,539.66백만 달러였던 모세혈관 혈액 수집 및 샘플링 장치 시장이 2030년까지 3625.50백만 달러에 도달할 것으로 예상하며, 2023년부터 2030년까지의 예측 기간 동안 4.55%의 CAGR을 기록할 것으로 분석했습니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

모세혈관 혈액 수집 및 샘플링 장치 시장 범위 및 세분화

시장 정의

모세혈관 혈액 수집 장치는 모세혈관 혈액을 채취하는 데 사용되는 장치입니다. 손가락, 귓볼 또는 발꿈치 구멍을 뚫어 모세혈관을 채취할 수 있습니다. 피부를 절개하여 수행할 수도 있습니다. 모세혈관 혈액 수집 및 샘플링 절차는 빈혈 위험을 낮추는 동시에 정확한 양의 혈액을 추출하기 때문에 널리 주목을 받고 있습니다. 체적 미세 샘플링 기술은 현재 모세혈관 혈액을 수집하는 데 인기가 있습니다. 또한 의사와 소비자의 요구를 충족하기 위해 새로운 기술 발전이 이루어지고 있습니다.

글로벌 모세혈관 혈액 수집 및 샘플링 장치 시장 역학

운전자

• Increase in demand for safe blood collection technologies

Clinical diagnostics are essential in many medical fields and play an important role in healthcare delivery. Millions of blood samples are collected each year for chemical and hematological testing to diagnose diseases, making blood sample collection critical to laboratory activities. The unsafe practice of blood collection, also known as phlebotomy, can have serious consequences for patients, including fainting, pain at the site of puncture, nerve damage, and, hematoma. Poor venipuncture practice has injured anatomical structures near the point of needle entry due to a lack of skilled professionals.

Furthermore, capillary blood testing requires less blood volume and can be done quickly and easily. As a result of the benefits of capillary blood sampling over venous blood sampling, physicians and patients prefer this method of blood sampling. As a result, there is a greater demand for more efficient capillary collection devices; thus, increased demand for safe blood collection technologies serves as a market driver.

• The rising availability of POC diagnostics

Point-of-care testing is diagnostic testing done at patients' bedsides in the home. Furthermore, it can be performed at any time and from any location. As a result, it is commonly referred to as bedside testing. Previously, testing was limited to laboratories where the specimen was sent, and obtaining the sample could take hours to days. This technique enables doctors to obtain lab-quality diagnostic results in minutes rather than days. It is not only quick, but it also allows clinicians to provide quality and effective patient care in the patient's home. POC diagnostics is becoming more popular as a result of its benefits.

For instance, according to various reports, the total worth of the global capillary blood collection and sampling devices  market was USD 40-45 billion, out of which the contribution of POC diagnostics is USD 12-13 billion.

The demand for POC testing has increased as health awareness, and the incidence of infectious diseases have increased. Traditional arterial and venous blood collection methods are painful and invasive, with a higher risk of needlestick injuries and contamination if not performed by trained personnel. On the other hand, the capillary blood collection method is less invasive, causes less pain, and has few side effects. Furthermore, it does not necessitate the use of skilled professionals; thus, it is a point care testing technique. Capillary collection devices have advanced in tandem with the rise in POC testing.

Opportunities

• Product innovation and technological advancements in capillary blood collection devices

Blood collection is a critical step in healthcare delivery. Blood sample analysis makes 70-80% of clinical decisions. With the growing trend of blood collection innovation, many companies are using safer, easier, and more efficient methods to collect blood samples. Capillary blood sampling is an excellent technique for pharmacy clinics. This method is preferred over venipuncture because of its simplicity and safety; additionally, it eliminates the need for skilled technicians. However, one of the drawbacks of finger sticks is that the droplets of blood vary in size. This can be overcome by introducing new and innovative products.

For instance- TAP, the world's first device that uses a push button to draw blood, was introduced by Seventh Sense Biosystems. This device is worn on the upper arm and draws blood with the push of a button. This makes high-quality lab testing more convenient and cost-effective.

Restraints/Challenges

• Higher risk related to the capillary blood assortment technologies

Higher risks related to the capillary blood assortment technologies and disadvantages of micro-collection of blood are expected to restrain the market growth in the forecast period. Capillary blood collection can sometimes rupture blood cells, resulting in inaccurate results. Bleeding and infection issues can arise with either method of collection.

This capillary blood collection and sampling devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the capillary blood collection and sampling devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Capillary Blood Collection and Sampling Devices Market

The COVID-19 pandemic has created both challenges and opportunities in the global market. Due to travel and trade restrictions worldwide, supply chain disruptions of medical devices/equipment and essential medical supplies were common during the pandemic. However, the point-of-care (POC) testing devices segment is experiencing significant growth due to the virus outbreak. As the virus spread, the number of infected patients grew rapidly, necessitating increased blood collection via various safety measures for antibody testing.

Recent developments

• In March 2020, B.D. and BioMedomics, a privately held clinical diagnostics company based in North Carolina, announced the development of a rapid test to assess current COVID-19 exposure in 15 minutes at home. This is an innovative testing device that will result in increased revenue generation.

Global Capillary Blood Collection and Sampling Devices Market Scope

The capillary blood collection and sampling devices market is segmented on the basis of product, modality, mode of administration, application, platform, procedure, age group, test type, technology, material, end user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Blood Sampling Devices
• Capillary Blood Collection Devices
• Rapid Test Cassette
• Remote Capillary Blood Collection Device
• Wearable Capillary Blood Collection Device

Modality

• Manual Sampling
• Automated/Autoinjection Sampling

 Mode of Administration

• Puncture
• Incision

Application

• Cardiovascular Disease
• Infection and Infectious Disease
• Respiratory Diseases
• Cancers
• Rheumatoid Arthritis
• Others

 Platform

• Enzyme Immunoassay Platform (Elisa Platform)
• PCR Platform
• Lateral Flow Immunoassay Platform
• ELTABA Platform
• Others

Procedure

• Conventional
• Point of Care Testing

Age Group

• Geriatrics
• Infant
• Pediatric
• Adult

Test Type

• Whole Blood Test
• Dried Blood Spot Tests
• Plasma/Serum Protein Tests
• Liver Panel/Liver Profile/Liver Function Tests
• Comprehensive Metabolic Panel (CMP) Tests
• Others

 Technology

• Volumetric Absorptive Microsampling
• Capillary Electrophoresis-Based Chemical Analysis
• Others

 Material

• Plastic
• Glass
• Stainless Steel
• Ceramic

 End User

• Laboratories
• Home Care Setting

 Distribution Channel

• Direct Tender
• Retail Sales
• Others

Capillary Blood Collection and Sampling Devices Market Regional Analysis/Insights

The capillary blood collection and sampling devices market is analysed and market size insights and trends are provided by country, product, modality, mode of administration, application, platform, procedure, age group, test type, technology, material, end user, distribution channel as referenced above.

The countries covered in the capillary blood collection and sampling devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the capillary blood collection and sampling devices market due to the adoption of advanced technologies and a greater focus on clinical research in this sector are likely to greatly benefit the market.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to increasing chronic diseases and a greater focus on clinical research in this sector are likely to greatly benefit the market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The capillary blood collection and sampling devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for capillary blood collection and sampling devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the capillary blood collection and sampling devices market. The data is available for historic period 2011-2021.

Competitive Landscape and Capillary Blood Collection and Sampling Devices Market Share Analysis

The capillary blood collection and sampling devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to capillary blood collection and sampling devices market.

Some of the major players operating in the capillary blood collection and sampling devices market are:

• B.D. (U.S.)
• Terumo BCT Inc. (U.S.)
• Fresenius KABI AG (Germany)
• Grifols S.A. (Spain)
• Nipro Medical Corporation (U.S.)
• Greiner AG (Austria)
• Quest Diagnostics Incorporated (U.S.)
• Mitra Industries Private Limited (India)
• SARSTEDT AG & Co. KG (Germany)
• CML Biotech (India)
• Macopharma (France)
• Neomedic Limited (U.S.)
• Haemonetics Corporation (U.S.)
• ICU Medical, Inc. (U.S.)
• SB-KAWASUMI LABORATORIES, INC. (Japan)
• Retractable Technologies Inc. (U.S.) 

SKU-54362